MD: UT Southwestern, Dallas, TX, 1993.
Residency: Children's Hospital of Dallas, Dallas, TX, 1996.
Fellowship: The Children's Hospital, Denver, CO, 2002.
Certification: American Board of Pediatrics, 1996; Sub-board of Pediatric Heme/Onc, 2002.
Histiocytic disorders: HLH and LCH
Cancer and Blood Diseases, Immune Deficiencies and Histiocytosis, Bone Marrow Transplantation BMT, Leukemia, Hemophagocytic lymphohistiocytosisHLH, Histiocytosis Center, Autoimmune Liver Disease, Rare Lung Diseases
Better understanding histiocytic disorders and developing novel therapies for them; regulation of the immune response; immunotherapy of cancer
Bone Marrow Transplantation and Immune Deficiency, Cancer and Blood Diseases, Immunobiology
Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.
Prospective two center study of CD38 bright CD8+ effector memory T-cells as a predictor of acute GVHD. Transplantation Reports. 2022; 7:100100.
Quercetin ameliorates XIAP deficiency-associated hyperinflammation. Blood. 2022; 140:706-715.
HLH: birds of a feather flock together. Blood. 2022; 140:167-168.
P1203: THE OPTIMIZED HLH INFLAMMATORY (OHI) INDEX IDENTIFIES LYMPHOMA PATIENTS WITH UNEXPECTEDLY HIGH MORTALITY NOT RELATED TO DISEASE PROGRESSION. HemaSphere. 2022; 6:1089-1090.
Emapalumab in primary haemophagocytic lymphohistiocytosis and the pathogenic role of interferon gamma: A pharmacometric model-based approach. British Journal of Clinical Pharmacology. 2022; 88:2128-2139.
Consensus-Based Guidelines for the Recognition, Diagnosis, and Management of Hemophagocytic Lymphohistiocytosis in Critically Ill Children and Adults. Critical Care Medicine. 2022; 50:860-872.
A Case of Chronic Lymphocytic Leukemia Complicated by Hemophagocytic Lymphohistiocytosis: Identifying the Aberrant Immune Response. Journal of General Internal Medicine. 2022; 37:1542-1546.
Malignancy-associated haemophagocytic lymphohistiocytosis. The Lancet Haematology. 2022; 9:e217-e227.
High risk of relapsed disease in patients with NK/T-cell chronic active Epstein-Barr virus disease outside of Asia. Blood Advances. 2022; 6:452-459.
Michael B. Jordan, MD, Alexei A. Grom, MD3/22/2021
Michael B. Jordan, MD5/7/2020
Michael B. Jordan, MD6/28/2019